The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
出版年份 2016 全文链接
标题
The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
作者
关键词
-
出版物
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 111, Issue 5, Pages 632-647
出版商
Springer Nature
发表日期
2016-03-22
DOI
10.1038/ajg.2016.54
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Long-Term Outcome of Patients With Crohn’s Disease Who Discontinued Infliximab Therapy Upon Clinical Remission
- (2015) Konstantinos Papamichael et al. Clinical Gastroenterology and Hepatology
- Su1329 Evolution After Anti-TNF Drug Discontinuation in Patients With Inflammatory Bowel Disease (IBD): A Multicenter Long-Term Follow-Up Study
- (2015) María José Casanova et al. GASTROENTEROLOGY
- Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
- (2014) B. Pariente et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Postoperative Therapy With Infliximab Prevents Long-term Crohn’s Disease Recurrence
- (2014) Miguel Regueiro et al. Clinical Gastroenterology and Hepatology
- Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study
- (2014) Armelle Chauvin et al. DIGESTIVE AND LIVER DISEASE
- Stopping Anti-TNF Agents in Patients with Crohnʼs Disease in Remission
- (2014) Dario Sorrentino et al. INFLAMMATORY BOWEL DISEASES
- P487 Factors influencing recurrence following suspension of biological treatment. Importance of mucosal healing
- (2014) V. Ciria et al. Journal of Crohns & Colitis
- P401 Outcome of infliximab discontinuation in IBD patients and therapy rechallenging in relapsers: Single centre preliminary data
- (2014) M. Marino et al. Journal of Crohns & Colitis
- P402 Normalized wall thickness at MRE predicts clinical remission in Crohn's disease after infliximab discontinuation: a 5 years follow-up
- (2014) M.L. Annunziata et al. Journal of Crohns & Colitis
- P363 Retreatment with infliximab in inflammatory bowel disease: tolerability and effectiveness of different re-induction regimens
- (2014) C. Felice et al. Journal of Crohns & Colitis
- Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission
- (2014) Masao Nawata et al. Modern Rheumatology
- Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy
- (2014) Cong Dai et al. PLoS One
- Frequency and prognostic role of mucosal healing in patients with Crohn’s disease and ulcerative colitis after one-year of biological therapy
- (2014) Klaudia Farkas WORLD JOURNAL OF GASTROENTEROLOGY
- P.02.11 WITHDRAWAL OF INFLIXIMAB (IFX) AFTER ACHIEVING REMISSION: OUTCOME IN A COHORT OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS
- (2013) I. Luppino et al. DIGESTIVE AND LIVER DISEASE
- P.08.2 THE LONG-TERM CLINICAL COURSE OF REFRACTORY CHRONIC POUCHITIS AFTER INFLIXIMAB THERAPY
- (2013) A. Calafiore et al. DIGESTIVE AND LIVER DISEASE
- Ten Years of Infliximab for Crohn’s Disease
- (2013) Emma J. Eshuis et al. INFLAMMATORY BOWEL DISEASES
- Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis
- (2013) Nikos Viazis et al. Journal of Crohns & Colitis
- When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel
- (2013) Valerie Pittet et al. Journal of Crohns & Colitis
- P403 Predictors of relapse after discontinuing anti-TNF therapy in Crohn's disease patients on deep remission
- (2013) A. Echarri et al. Journal of Crohns & Colitis
- Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
- (2013) Klaudia Farkas et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease
- (2013) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy
- (2012) T. Molnár et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- PMO-227 Infliximab induction therapy alone for ulcerative colitis does not result in long term remission
- (2012) A J Brooks et al. GUT
- Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease
- (2012) Alessandro Armuzzi et al. Journal of Crohns & Colitis
- Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
- (2012) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Crohn’s disease genotypes of patients in remissionvsrelapses after infliximab discontinuation
- (2012) Cathy Lu WORLD JOURNAL OF GASTROENTEROLOGY
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Long-term outcome of treatment with infliximab in pediatric-onset Crohnʼs disease: A population-based study
- (2011) Valérie Crombé et al. INFLAMMATORY BOWEL DISEASES
- Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
- (2011) Kofi Clarke et al. INFLAMMATORY BOWEL DISEASES
- Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease
- (2011) Mamoru Watanabe et al. Journal of Crohns & Colitis
- The duration of effect of infliximab maintenance treatment in paediatric Crohn’s disease is limited
- (2010) C. I. De Bie et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
- (2010) A. W. G. Waugh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organization: When to Start, When to Stop, Which Drug to Choose and How to Predict Response?
- (2010) Geert R D'Haens et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data
- (2010) Stefan Schreiber et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
- (2010) Y. Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-TNF and Crohns Disease: When Should We Stop?
- (2010) Edouard Louis et al. CURRENT DRUG TARGETS
- CO12 LONG TERM EFFICACY OF INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE AT A SINGLE TERTIARY CENTER
- (2010) F. Nuti et al. DIGESTIVE AND LIVER DISEASE
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
- (2009) Filip Baert et al. GASTROENTEROLOGY
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Effect of discontinuing TNFα antagonist therapy in patients with remission of rheumatoid arthritis
- (2009) Olivier Brocq et al. JOINT BONE SPINE
- Long-term Methotrexate for Crohnʼs Disease
- (2009) Eugeni Domènech et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Infliximab Reintroduction is Not Associated to a Higher Rate of Immune-related Adverse Effects in Patients With Inflammatory Bowel Disease Initially Treated With a Three-infusion Induction Regimen
- (2009) Eugeni Domènech et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- 12-Month Follow-up After Successful Infliximab Therapy in Pediatric Crohn Disease
- (2009) Jan Wynands et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Clinical implications of mucosal healing for the management of IBD
- (2009) Guillaume Pineton de Chambrun et al. Nature Reviews Gastroenterology & Hepatology
- Is the efficacy of successful infliximab induction therapy maintained for one year lasting without retreatment in different behavior types of Crohn's disease?
- (2008) T. Molnár et al. Journal of Crohns & Colitis
- Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience
- (2008) L. Guidi et al. Techniques in Coloproctology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now